Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4-dione | 488097-06-9 | 99.7% | 440.73 | C16H11ClF6N4O2 | 50 MG
SDP

Catalog No. 5000211335
Encompass_Preferred

GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS-penetrant, non-competitive antagonist of the glucagon-like peptide-1 receptor (GLP-1R). It is used in preclinical biochemical and pharmacological research to study GLP-1R signaling and receptor pharmacology. The compound is supported by supplier analytical data and safety documentation for laboratory use.

  • Orally active and CNS penetrant.
  • Non-competitive antagonist of GLP-1R.
  • Documented in vitro activity (IC50: 650 nM).
  • Provided with analytical data and safety documentation.
  • Available in small research quantities, including 50 mg.

Catalog No. 50-002-11335 Supplier Medchemexpress LLC Supplier No. HY10111650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS-penetrant, non-competitive antagonist of the glucagon-like peptide-1 receptor (GLP-1R). It is used in preclinical biochemical and pharmacological research to study GLP-1R signaling and receptor pharmacology. The compound is supported by supplier analytical data and safety documentation for laboratory use.

  • Orally active and CNS penetrant.
  • Non-competitive antagonist of GLP-1R.
  • Documented in vitro activity (IC50: 650 nM).
  • Provided with analytical data and safety documentation.
  • Available in small research quantities, including 50 mg.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.